Skip to main content
  • Original article
  • Open access
  • Published:

Serum salusin-β levels as predictors of coronary artery disease in obese Egyptian women

En

Abstract

Background

Obesity is a growing health concern that has become an epidemic all over the world. Obesity is associated with coronary artery disease (CAD). Salusin-β is an endogenous bioactive peptide that accelerates inflammatory responses in vascular endothelial cells and increases oxidative stress. The objective of this study was to explore the potential roles of salusin-β in endothelial dysfunction in CAD. Also, we aimed to evaluate the association between salusin-β with severity of CAD in obese Egyptian women.

Patients and methods

This cross-sectional study enrolled 95 obese women who were classified into two groups: 58 patients without CAD and 37 patients without CAD. All patients were investigated using a 12-lead standard ECG, echocardiography, and coronary arteriography. Salusin-β levels were measured by enzyme-linked immunosorbent assay.

Results

Salusin-β levels were significantly higher in obese patients with CAD compared with patients without CAD. Salusin-β levels were positively correlated with cardiometabolic risks and severity of coronary occlusion. Serum salusin-β levels, high-sensitivity C-reactive protein, and BMI were independently correlated with CAD and BMI. Homeostatic model assessment of insulin resistance, high-sensitivity C-reactive protein, and uric acid were the main associated variables of serum salusin-β levels among other clinical and laboratory biomarkers. The diagnostic power of serum salusin-β levels in differentiating CAD from obese patients without CAD was highly sensitive (97.2%) and the specificity was 98.3%.

Conclusion

The higher levels of salusin-β levels in obesity, as well as CAD, were positively correlated with cardiometabolic risk factors and severity of coronary occlusion. Therefore, salusin-β levels seem to be a noninvasive biomarker of CAD.

References

  1. Lu Y, Hajifathalian K, Ezzati M, Woodward M, Rimm EB, Danaei G. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet 2014; 383:970–983.

    Article  Google Scholar 

  2. Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation 2005; 111: 363–368.

    Article  Google Scholar 

  3. Shichiri M, Ishimaru S, Ota T, Nishikawa T, Isogai T, Hirata Y. Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities. Nat Med 2003; 9: 1166–1172.

    Article  CAS  Google Scholar 

  4. Sun HJ, Liu TY, Zhang F, Xiong XQ, Wang JJ, Chen Q et al. Salusin-β contributes to vascular remodeling associated with hypertension via promoting vascular smooth muscle cell proliferation and vascular fibrosis. Biochim Biophys Acta 2015; 1852: 1709–1718.

    Article  CAS  Google Scholar 

  5. Sun HJ, Zhao MX, Liu TY, Ren XS, Chen Q, Li YH et al. Salusin-β induces foam cell formation and monocyte adhesion in human vascular smooth muscle cells via miR155/NOX2/NFκB pathway. Sci Rep 2016; 6: 23596.

    Article  CAS  Google Scholar 

  6. Xu T, Zhang Z, Liu T, Zhang W, Liu J, Wang W et al. Salusin-β contributes to vascular inflammation associated with pulmonary arterial hypertension in rats. J Thorac Cardiovasc Surg 2016; 152: 1177–1187.

    Article  CAS  Google Scholar 

  7. Fujimoto K, Hayashi A, Kamata Y, Ogawa A, Watanabe T, Ichikawa R et al. Circulating levels of human salusin-beta, a potent hemodynamic and atherogenesis regulator. PLoS ONE 2013; 8: e76714.

    Article  CAS  Google Scholar 

  8. Zhao MX, Zhou B, Ling L, Xiong XQ, Zhang F, Chen Q et al. Salusin-β contributes to oxidative stress and inflammation in diabetic cardiomyopathy. Cell Death Dis 2017; 8: e2690.

    Article  CAS  Google Scholar 

  9. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.

    Article  CAS  Google Scholar 

  10. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Arterioscler ThrombVasc Biol 2006; 26: 968–976.

    Article  CAS  Google Scholar 

  11. Virdis A, Santini F, Colucci R, Duranti E, Salvetti G, Rugani I et al. Vascular generation of tumor necrosis factor-α reduces nitric oxide availability in small arteries from visceral fat of obese patients. J Am Coll Cardiol 2011; 58: 238–247.

    Article  CAS  Google Scholar 

  12. Virdis A. Endothelial dysfunction in obesity: role of inflammation. High Blood Press Cardiovasc Prev 2016; 23: 83–85.

    Article  CAS  Google Scholar 

  13. Reho JJ, Rahmouni K. Oxidative and inflammatory signals in obesity-associated vascular abnormalities. Clin Sci 2017; 131: 1689–1700.

    Article  CAS  Google Scholar 

  14. Koya T, Miyazaki T, Watanabe T, Shichiri M, Atsumi T, Kim-Kaneyama JR et al. Salusin-β accelerates inflammatory responses in vascular endothelial cells via NF-kappaB signaling in LDL receptor-deficient mice in vivo and HUVECs in vitro. Am J Physiol Heart Circ Physiol 2012; 303: H96–H105.

    Article  CAS  Google Scholar 

  15. Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 2013; 309: 71–82.

    Article  CAS  Google Scholar 

  16. Artham SM, Lavie CJ, Milani RV, Ventura HO. Value of weight reduction in patients with cardiovascular disease. Curr Treat Options Cardiovasc Med 2010; 12: 21–35.

    Article  Google Scholar 

  17. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease. risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 2009; 53: 1925–1932.

    Article  Google Scholar 

  18. Lavie CJ, Milani RV, Artham SM, Patel DA, Ventura HO. The obesity paradox, weight loss, and coronary disease. Am J Med 2009; 122: 1106–1114.

    Article  CAS  Google Scholar 

  19. Niraj A, Pradahan J, Fakhry H, Veeranna V, Afonso L. Severity of coronary artery disease in obese patients undergoing coronary angiography: ‘Obesity Paradox’ revisited. Clin Cardiol 2007; 30: 391–396.

    Article  Google Scholar 

  20. Parsa AFZ, Jahanshahi B. Is the relationship of body mass index to severity of coronary artery disease different from that of waist-to-hip ratio and severity of coronary artery disease? Paradoxical findings. Cardiovasc J Afr 2015; 26: 13–16

    Article  CAS  Google Scholar 

  21. Watanabe T, Sato K, Itoh F, Iso Y, Nagashima M, Hirano T et al. The roles of salusins in atherosclerosis and related cardiovascular diseases. J Am Soc Hypertens 2011; 5: 359–365.

    Article  CAS  Google Scholar 

  22. Ross R. Atherosclerosis − an inflammatory disease. N Engl J Med 1999; 340: 115–126.

    Article  CAS  Google Scholar 

  23. Zhou CH, Liu L, Liu L, Zhang MX, Guo H, Pan J et al. Salusin-β not salusin-α promotes vascular inflammation in ApoE-deficient mice via the I kBa/NF-kB pathway. PLoS ONE 2014; 9: e91468.

    Article  Google Scholar 

  24. Watanabe T, Nishio K, Kanome T, Matsuyama T, Koba S, Sakai T et al. Impact of salusin-α and −β on human macrophage foam cell formation and coronary atherosclerosis. Circulation 2008; 117: 638–648.

    Article  CAS  Google Scholar 

  25. Sato K, Watanabe R, Itoh F, Shichiri M, Watanabe T. Salusins: potential use as a biomarker for atherosclerotic cardiovascular diseases. Int J Hypertens 2013; 2013: 965140.

    Article  Google Scholar 

  26. Kołakowska U, Kuroczycka-Saniutyc E, Wasilewska A, Olański W. Is the serum level of salusin-β associated with hypertension and atherosclerosis in the pediatric population? Pediatr Nephrol 2015; 30: 523–531.

    Article  Google Scholar 

  27. Liu J, Ren YG, Zhang LH, Tong YW, Kang L. Serum salusin-β levels are associated with the presence and severity of coronary artery disease. J Investig Med 2015; 63: 4.

    Article  Google Scholar 

  28. Niepolski L, Grzegorzewska AE. Salusins and adropin: new peptides potentially involved in lipid metabolism and atherosclerosis. Adv Med Sci 2016; 61: 282–287.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nearmeen M. Rashad MD.

Additional information

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rashad, N.M., Ashour, W.M.R., Samir, G.M. et al. Serum salusin-β levels as predictors of coronary artery disease in obese Egyptian women. Egypt J Intern Med 31, 360–367 (2019). https://doi.org/10.4103/ejim.ejim_123_18

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/ejim.ejim_123_18

Keywords